lower
respiratori
tract
infect
commonli
caus
virus
caus
signific
morbid
mortal
among
children
earli
identif
patholog
agent
caus
infect
essenti
avoid
unnecessari
antibiot
use
improv
patient
manag
multiplex
pcr
techniqu
recent
develop
detect
multipl
viral
pathogen
use
singl
pcr
reaction
studi
identifi
viral
pathogen
children
respiratori
infect
collect
nasopharyng
aspir
infant
month
old
lower
respiratori
tract
infect
treat
vietnam
nation
children
hospit
novemb
june
assess
presenc
viru
type
subtyp
multiplex
pcr
use
xtag
respiratori
viral
panel
rvp
assay
overal
sampl
posit
least
one
viru
correspond
infect
multipl
virus
e
common
virus
respiratori
syncyti
viru
enteroviru
rhinoviru
ese
virus
frequent
among
younger
patient
month
old
caus
symptom
similar
bronchiol
pneumonia
e
common
clinic
manifest
caus
respiratori
tract
infect
bronchiol
elev
neutrophil
level
associ
adenoviru
infect
result
show
xtag
respiratori
viral
panel
rvp
effect
detect
multipl
virus
caus
respiratori
infect
children
nasopharyng
aspir
good
sampl
choic
detect
respiratori
virus
children
appli
approach
clinic
set
would
improv
patient
manag
allow
earli
diagnosi
thu
avoid
unnecessari
use
antibiot
acut
respiratori
infect
ari
common
among
children
worldwid
although
similar
incid
rate
develop
develop
countri
mortal
rate
higher
develop
countri
ari
respons
approxim
death
children
year
death
occur
subsaharan
africa
southern
region
asia
virus
main
caus
agent
respiratori
infect
bacteria
fungi
parasit
caus
well
e
lead
aricaus
virus
rhinoviru
respiratori
syncyti
viru
rsv
rsv
affect
mainli
infant
year
age
virus
primarili
infect
replic
airway
epithelium
caus
injuri
proxim
conduct
distal
airway
alveoli
parenchyma
ga
exchang
occur
viral
infect
multipl
clinic
manifest
pneumonia
defin
inflamm
lung
parenchyma
condit
often
associ
visibl
chang
chest
xray
ctscan
gallium
scan
abnorm
alveolar
ga
exchang
e
present
viral
pneumonia
vari
consider
depend
age
immunolog
compet
host
well
viral
pathogen
viral
pneumonia
import
caus
morbid
mortal
immun
compromis
individu
children
e
clinic
present
depend
specif
caus
agent
typic
includ
fever
lower
respiratori
tract
symptom
tachypnoea
nonproduct
cough
wheez
increas
breath
sound
inappropri
antibiot
use
acut
respiratori
infect
led
increas
antimicrobi
resist
erefor
earli
detect
pathogen
caus
respiratori
infect
may
prevent
antibiot
issu
help
improv
patient
manag
howev
lack
rapid
afford
sensit
specif
diagnost
tool
one
main
reason
ineffici
diagnosi
pcr
revolution
field
infecti
diseas
diagnosi
multiplex
pcr
variant
use
sever
pair
primer
amplifi
one
target
sequenc
singl
tube
develop
detect
differ
virus
singl
sampl
previou
studi
show
multiplex
assay
use
limit
amount
sampl
similar
perform
tradit
method
use
clinic
diagnosi
addit
benefit
detect
larg
number
virus
short
time
e
xtag
respiratori
viral
panel
fast
rvp
fast
qualit
nucleic
acid
multiplex
test
simultan
detect
identifi
presenc
nucleic
acid
multipl
respiratori
virus
singl
tube
work
sampl
nasopharyng
swab
nasal
aspir
nasopharyng
aspir
bronchoalveolar
lavag
individu
suspect
respiratori
tract
infect
e
xtag
rvp
fast
test
shown
superior
sensit
compar
singl
realtim
pcr
convent
pcr
assay
present
studi
use
xtag
rvp
fast
assay
identifi
virus
caus
ri
children
relationship
specif
virus
clinic
outcom
crosssect
studi
held
novemb
june
enrol
pediatr
infant
month
old
lower
respiratori
tract
infect
treat
vietnam
nation
children
hospit
collect
nasopharyng
aspir
particip
patient
divid
age
group
e
first
group
includ
infant
month
n
breastf
like
receiv
passiv
immun
mother
e
second
group
includ
infant
month
old
n
spent
time
home
e
third
group
includ
infant
month
old
n
attend
differ
nurseri
studi
approv
vnch
ethic
committe
approv
number
written
inform
consent
obtain
parent
legal
guardian
children
enrol
studi
collect
ml
nasopharyng
aspir
particip
store
sampl
analysi
npa
collect
perform
train
nurs
e
cathet
insert
nostril
depth
cm
drawn
back
appli
gentl
suction
syring
npa
sampl
patient
subject
total
nucleic
extract
addit
intern
control
bacteriophag
use
magna
pure
lc
total
nucleic
acid
isol
kit
roch
diagnost
germani
magna
pure
lc
platform
follow
manufactur
instruct
e
method
base
magneticbead
technolog
e
procedur
includ
cellular
destruct
nucleic
acid
bind
bead
wash
step
remov
cellular
purifi
nucleic
acid
elut
extract
nucleic
acid
elut
elut
buffer
store
rvp
fast
assay
clude
subtyp
respiratori
syncyti
viru
b
rsva
rsvb
enterovirus
includ
rhinovirus
evrhi
human
parainfluenza
virus
human
metapneumoviru
hmpv
adenoviru
adv
human
coronaviru
hcov
hcov
hcov
hcov
human
bocaviru
hbov
e
assay
perform
accord
manufactur
instruct
assay
perform
control
use
bacteriophag
lambda
includ
everi
run
e
assay
compris
two
step
multiplex
pcr
amplif
step
hybrid
step
multiplex
rtpcr
pcr
amplif
perform
appli
biosystem
gene
amp
pcr
appli
biosystem
usa
follow
program
preheat
min
templat
denatur
min
cycl
final
extens
min
kept
readi
tousl
e
hybrid
reaction
perform
luminex
system
lmd
toronto
canada
e
hybrid
assay
includ
xtag
rvp
fast
bead
mix
amplifi
nucleic
acid
streptavidin
rphycoerythrin
conjug
sape
report
reagent
incub
minut
signal
acquisit
done
luminex
instrument
data
analyz
report
xtag
data
analysi
softwar
tda
e
infect
classifi
pneumonia
bronchiol
bronchiti
base
clinic
find
chest
xray
cxr
pneumonia
defin
ari
character
infiltr
cxr
bronchiol
defin
ari
children
year
present
wheez
hyperaer
atelectasi
peribronchi
thicken
cxr
bronchiti
defin
ari
children
year
old
present
wheez
hyperaer
peribronchi
thicken
cxr
analysi
statist
analysi
perform
use
fisher
exact
test
p
consid
signific
spss
e
xtag
rvp
fast
assay
system
detect
one
respiratori
virus
sampl
tabl
rsv
common
viru
follow
enterovirusrhinoviru
evrhi
parainfluenza
piv
adenoviru
adv
influenza
ab
human
bocaviru
hbov
overal
sampl
posit
singl
viru
virus
virus
virus
group
rsv
evrhi
detect
frequent
children
month
figur
virus
differ
among
age
group
children
viral
infect
upper
respiratori
tract
show
symptom
runni
nose
cough
hoars
also
present
lower
respiratori
tract
symptom
wheez
sever
cough
breathless
respiratori
distress
may
due
bronchiol
pneumonia
divid
patient
accord
three
clinic
manifest
pneumonia
bronchiol
bronchiti
investig
whether
detect
virus
associ
specif
clinic
manifest
analysi
show
case
rsv
infect
induc
bronchiol
n
follow
pneumonia
n
p
bronchiti
n
p
evrhi
infect
often
induc
pneumonia
bronchiol
n
instead
bronchiti
n
p
figur
total
posit
specimen
singl
infect
doubl
infect
tripl
infect
respiratori
syncyti
viru
rsv
infect
group
preval
pneumonia
symptom
significantli
lower
bronchiol
symptom
significantli
higher
bronchiti
symptom
enteroviru
ev
rhinoviru
rhi
infect
group
preval
pneumonia
symptom
significantli
higher
bronchiti
symptom
virus
show
similar
preval
manifest
p
virus
show
similar
preval
clinic
manifest
viru
infect
respiratori
virus
may
caus
symptom
nasal
congest
runni
nose
wheez
cough
found
signific
associ
virus
specif
symptom
studi
whether
presenc
specif
viral
agent
associ
clinic
paramet
respiratori
rate
breathsmin
heart
rate
beatsmin
peripher
capillari
oxygen
satur
spo
blood
test
paramet
white
blood
count
neutrophil
count
creactiv
protein
crp
elev
neutrophil
associ
adenoviru
infect
p
figur
ere
notic
associ
crp
slightli
higher
adenoviru
enterovirusrhinoviru
infect
group
neg
group
p
respect
neutrophil
significantli
higher
adenoviru
infect
group
neg
group
p
studi
calcul
frequenc
differ
respiratori
virus
present
children
lower
respiratori
tract
infect
vietnam
nation
children
hospit
e
high
proport
virus
detect
pediatr
ari
patient
agre
previou
studi
done
vietnam
sever
children
respiratori
infect
virus
detect
rare
north
vietnam
due
differ
locat
climat
south
north
vietnam
rsv
ev
rhi
frequent
virus
similar
find
studi
done
southern
vietnam
rsv
rhinovirus
influenza
virus
parainfluenza
virus
enterovirus
coronavirus
certain
strain
adenoviru
lead
caus
viral
respiratori
infect
children
e
nasal
respiratori
secret
children
viral
respiratori
tract
infect
contain
virus
infect
adult
e
increas
output
virus
togeth
overal
reduc
attent
hygien
make
children
like
spread
infect
other
virus
invad
cell
respiratori
tract
trigger
inflamm
mucu
product
caus
nasal
congest
runni
nose
scratchi
throat
cough
e
small
airway
young
children
significantli
narrow
inflamm
mucu
make
breath
difficult
airway
problem
common
infect
caus
parainfluenza
virus
rsv
human
metapneumoviru
bronchiol
occur
predominantli
first
year
life
decreas
frequenc
second
third
year
character
inflammatori
obstruct
small
airway
hyperinfl
lung
typic
present
along
breath
problem
wheez
rsv
primari
caus
agent
bronchiol
worldwid
caus
percent
ari
high
season
rsv
viru
associ
bronchiol
studi
neutrophil
immun
cell
present
mani
lung
diseas
associ
acut
respiratori
distress
syndrom
ard
may
contribut
acut
lung
injuri
neutrophil
poorli
studi
respect
viral
infect
observ
associ
elev
neutrophil
count
adenoviru
infect
might
indic
associ
neutrophil
count
damag
alveolar
epithelium
find
biomark
diagnos
specif
viral
infect
essenti
improv
patient
care
crp
acut
phase
protein
synthes
liver
respons
increas
use
biomark
inflamm
distinguish
bacteri
viral
infect
well
known
crp
level
differ
differ
viral
respiratori
infect
studi
found
signific
associ
crp
specif
viru
bronchiol
common
clinic
characterist
lower
respiratori
tract
infect
vietnam
nation
children
hospit
xtag
rvp
fast
effect
detect
differ
viru
specimen
low
viral
load
e
assay
appli
clinic
screen
multipl
respiratori
viral
infect
e
data
use
support
find
studi
includ
within
articl
studi
approv
vnch
ethic
committe
approv
number
written
inform
consent
obtain
patient
enrol
studi
legal
guardian
e
author
declar
conflict
interest
regard
public
articl
